1-3 of 3
Tadashi Murase, MD
Close
Sort by
Journal Articles

Silent NK/T Cell Reactions Against Dasatinib during Sustained Deep Molecular Response before Discontinuation Are Associated with Longer Treatment-Free Remission: A Multicenter, Single-Arm, Phase 2 Study

Takashi Kumagai, MD PhD, Chiaki Nakaseko, MD PhD, Kaichi Nishiwaki, MD, Chikashi Yoshida, MD PhD, Kazuteru Ohashi, MD PhD, Naoki Takezako, MD PhD, Hina Takano, MD PhD, Yasuji Kouzai, MD PhD, Tadashi Murase, MD PhD, Kosei Matsue, MD PhD, Satoshi Morita, PhD Prof., Junichi Sakamoto,, MD PhD, Hisashi Wakita, MD PhD, Hisashi Sakamaki, MD PhD, Koiti Inokuchi, MD PhD Prof.
Journal: Blood
Blood (2019) 134 (Supplement_1): 4154.
https://doi.org/10.1182/blood-2019-130504
Published: 2019
Journal Articles

Discontinuation of Dasatinib after Deep Molecular Response for over 2 Years in Patients with Chronic Myelogenous Leukemia and the Unique Profiles of Lymphocyte Subsets for Successful Discontinuation: A Prospective, Multicenter Japanese Trial (D-STOP Trial)

Takashi Kumagai, MD PhD, Chiaki Nakaseko, MD, Kaichi Nishiwaki, MD PhD, Chikashi Yoshida, MD PhD, Kazuteru Ohashi, Naoki Takezako, MD PhD, Hina Takano, MD PhD, Yasuji Kouzai, MD PhD, Tadashi Murase, MD PhD, Kosei Matsue, MD PhD, Satoshi Morita, PhD Prof, Junichi Sakamoto, MD PhD, Hisashi Wakita, MD PhD, Hisashi Sakamaki, MD PhD, Koiti Inokuchi, MD PhD Prof
Journal: Blood
Blood (2016) 128 (22): 791.
https://doi.org/10.1182/blood.V128.22.791.791
Published: 2016
Journal Articles

Development of a Diagnostic Support System for Hematological Disorders Using a Self-Organizing Map.

Yohko Kawai, MD, Nobuko Shimizu, Minoru Okamoto, Takayuki Mitsuhashi, MD, Naoki Minamide, Hisako Kataguru, Tadashi Murase, MD, Naoshiro Minamiide, Takeyoshi Fujihara, Toshio Kawaguchi, Kiyoaki Watanabe, MD
Journal: Blood
Blood (2004) 104 (11): 5298.
https://doi.org/10.1182/blood.V104.11.5298.5298
Published: 2004